Lot V251029-17 — MTI, Melanotan1 10mg — third-party test record
This page is the permanent record for one lot of material: what was tested, by which laboratory, under which method, and what the report says. The report images below are the source documents.
Test summary
| Test | Compound | Presentation | Lot | Date | Laboratory | Method | Standard | Result | Criterion |
|---|---|---|---|---|---|---|---|---|---|
| Purity | MTI, Melanotan1 | 10mg | V251029-17 | 11/13/2025 | Vanguard Laboratory, A2LA cert 6377.01.01 | HPLC-UV/VIS | — | 99.57% | — |
The reports
What these tests measure
Purity
A purity assay separates the sample on a reversed-phase HPLC column and reports the target peak as a percentage of total peak area.
It answers one analytical question only: how much of the material in the vial is the identified compound, and what else is present.
Further reading: our testing methodology and the bench calculator.
Other records
- Every sample tested under laboratory batch V251029-17
- Purity test records (HPLC)
- Bacterial endotoxin records (LAL, USP <85>)
- Residual-solvent records (GC)
- Heavy-metal records (ICP-MS)
Cite this record
Licensed Peptides, Lot V251029-17 test record (MTI, Melanotan1 10mg), retrieved 13 September 2026, https://licensedpeptides.com/lab-reports/v251029-17-mti-melanotan1-10mg/.
Data on this page is published under CC BY 4.0. Reuse it, with attribution. Machine-readable copies: data.csv · data.json.
For laboratory research use only. Not for human or veterinary use.